CELH
Celsius Holdings, Inc.
CELH has the edge over PRMB overall, supported by stronger fundamentals and stronger valuation.
PRMB
Primo Brands Corporation
PRMB has lower modeled downside risk, despite its lower overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
PRMB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
PRMB's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over PRMB in the historical PE scenario, which offers more potential upside but is not a forecast.
PRMB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 17x | $23.81 | — |
| Cheap | 28x | $15.94 | -33% |
| Current | 42x | $23.81 | — |
| Fair | 56x | $32.16 | +35% |
| Expensive | 165x | $94.32 | +296% |
Historical ranges are pointers, not guarantees.
PRMB's PE is in its cheap range at 42x. If earnings grow as analysts expect, today's price would be 17x next year's earnings.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over PRMB on the outlook, with more favorable profitability expectations.
PRMB Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for PRMB, with profitability holding steady. However, they disagree widely on these estimates.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
PRMB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.38 | +142% |
| Q3 2026 | $0.57 | +$0.88 |
| Q2 2026 | $0.27 | +$0.62 |
| Q1 2026 | $0.15 | +$0.32 |
| Q4 2025 | $0.16 | +$0.26 |
| Q3 2025 | -$0.31 | -174% |
| Q2 2025 | -$0.35 | -156% |
| Q1 2025 | -$0.17 | -133% |
| Q4 2024 | -$0.10 | -125% |
PRMB has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH's revenue has grown year over year for six quarters in a row: $847M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over PRMB on profitability, with a higher operating margin.
PRMB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.8B | +3.1% |
| Q2 2026 | $1.8B | +3.8% |
| Q1 2026 | $1.6B | +0.8% |
| Q4 2025 | $1.6B | +11% |
| Q2 2025 | $1.7B | +32% |
| Q1 2025 | $1.6B | +42% |
| Q4 2024 | $1.4B | +29% |
| Q2 2024 | $1.3B | +192% |
PRMB has the edge over CELH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +5.4 points |
| Q2 2026 | 10% | +3.5 points |
| Q1 2026 | 8.5% | -1 points |
| Q4 2025 | 1.2% | -5.7 points |
| Q3 2025 | 8.3% | N/A |
| Q2 2025 | 6.5% | -6.6 points |
| Q1 2025 | 9.5% | -2 points |
| Q4 2024 | 6.9% | -1.5 points |
PRMB's operating margin was 14% last quarter, up 5.4 points from the same quarter a year ago, near the top of its range since 2019.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
PRMB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $214.9M | +28% |
| Q2 2026 | $142.4M | +41% |
| Q1 2026 | -$700K | +$22.5M |
| Q4 2025 | $57.3M | -64% |
| Q3 2025 | $167.7M | +$167.7M |
| Q2 2025 | $101.1M | +80% |
| Q1 2025 | -$23.2M | -$5.7M |
| Q4 2024 | $158.1M | +$198M |
PRMB has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has 255M diluted shares, down 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
PRMB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -426K shares |
| 1 year | -2.4% | -8.8M shares |
| 3 years | +128% | +205M shares |
| 5 years | +126% | +204M shares |
| Available history | +168% | +229M shares |
PRMB has the edge over CELH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $22.3M |
| Q2 2026 | $15.6M |
| Q1 2026 | $32.2M |
| Q4 2025 | $124.7M |
| Q3 2025 | $75.8M |
| Q2 2025 | $101.8M |
| Q1 2025 | $119.2M |
| Q4 2024 | $10.1M |
PRMB spent $195M buying back its own shares over the past year, down 37% from the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over PRMB on leverage, with a lower net debt burden relative to earnings.
PRMB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.9x | Elevated |
| Q2 2026 | 4.4x | High |
| Q1 2026 | 4.7x | High |
| Q4 2025 | 4.6x | High |
| Q3 2025 | 5.3x | High |
| Q2 2024 | 1.1x | Healthy |
| Q1 2024 | 1.6x | Healthy |
| Q4 2023 | 9.1x | High |
PRMB's net debt is about 3.9 years of its operating earnings (EBITDA), down from 5.3 years a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
PRMB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.8 | Neutral |
| Stochastic | 48.1 | Neutral |
PRMB's weekly RSI is 60 (neutral) and its Stochastic is 48 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH has the edge over PRMB on valuation relative to its sector.
PRMB PE vs Consumer Defensive Sector
| Metric | PRMB | Sector median | Relative |
|---|---|---|---|
| PE | 42x | 19x | 114% above |
| PE % | 20 | 18 | 2 pts above |
PRMB is trading at 42x earnings, a 114% premium to the Consumer Defensive sector's median of 19x.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
PRMB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $20.5 | 16% above |
| 20 week MA | $22.0 | 8.1% above |
| 50 week MA | $20.9 | 14% above |
| 100 week MA | $24.6 | 3.1% below |
| 200 week MA | $21.3 | 12% above |
PRMB has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
PRMB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.5 | $16.0 | +39% |
| 2021 | $16.0 | $17.5 | +9.2% |
| 2022 | $17.5 | $15.6 | -11% |
| 2023 | $15.6 | $15.1 | -3.5% |
| 2024 | $15.1 | $31.2 | +107% |
| 2025 | $31.2 | $16.6 | -47% |
| 2026 YTD | $16.6 | $23.8 | +43% |
PRMB has the edge over CELH on returns for 2026, with the stronger performance.